Alymsys
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Alymsys, covering 2022-04-13 to 2026-02-06. Get the full timeline:
Most recent: EMA Authorised: Alymsys (bevacizumab) — Mabxience Research SL
2 regulatory and trial events tracked for Alymsys, covering 2022-04-13 to 2026-02-06. Get the full timeline:
Most recent: EMA Authorised: Alymsys (bevacizumab) — Mabxience Research SL